pentobarbital will reduce the extent or impact of armodafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.

pentobarbital will lower the level or outcome of venetoclax by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will reduce the level or influence of diazepam intranasal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Solid or average CYP3A4 inducers might enhance rate of diazepam elimination; consequently, efficacy of diazepam may very well be lowered.

The withdrawal syndrome from drugs like Nembutal can be quite unsafe a result of the likely development of harmful signs.

pentobarbital decreases levels of amphotericin B deoxycholate by inhibition of GI absorption. Applies only to oral kind of both brokers. Small/Significance Not known.

pentobarbital will reduce the level or result of cortisone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will decrease the extent or impact of ondansetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. No dosage adjustment for ondansetron is recommended for patients on these drugs.

pentobarbital will minimize the level or result of nateglinide by impacting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Keep an eye on.

pentobarbital will reduce the extent or outcome of etravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will minimize the level or impact of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Steer clear of coadministration of bedaquiline with robust CYP3A4 inducers as a consequence of potential here for reduced therapeutic effect

pentobarbital will decrease the extent or outcome of diazepam buccal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Solid or moderate CYP3A4 inducers may possibly raise amount of diazepam elimination; consequently, efficacy of diazepam can be decreased.

pentobarbital will decrease the extent or outcome of fruquintinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. If coadministration with reasonable CYP3A4 inducers is unavoidable, proceed to administer fruquintinib at suggested dosage.

pentobarbital will lower the level or influence of iloperidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

pentobarbital will minimize the level or outcome of acalabrutinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.